Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Themis Medicare Limited ( (IN:THEMISMED) ) has issued an announcement.
Themis Medicare Limited has disclosed that it received a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 March 2026. The certificate, issued by its registrar and share transfer agent MUFG Intime India Private Limited, confirms that all securities submitted for dematerialisation during the quarter were duly processed and aligned with existing listed securities.
MUFG Intime further certified that security certificates received for dematerialisation were verified, mutilated, cancelled, and replaced in the register of members with the depositories’ names as registered owners within prescribed timelines. The disclosure underscores Themis Medicare’s adherence to regulatory requirements on share dematerialisation, reinforcing procedural transparency and compliance for shareholders and market participants.
More about Themis Medicare Limited
Themis Medicare Limited is an Indian pharmaceutical company engaged in manufacturing and marketing medicines and healthcare products. The company operates from facilities in Gujarat and maintains a corporate office in Mumbai, with its shares listed on both BSE and NSE under the symbol THEMISMED.
Average Trading Volume: 6,755
Technical Sentiment Signal: Sell
Current Market Cap: 7.41B INR
For a thorough assessment of THEMISMED stock, go to TipRanks’ Stock Analysis page.